Editorial standards · July 24, 2026
These are the rules we use to keep hope, evidence, and commercial incentives from collapsing into one another.
Commercial relationships do not determine which compounds we cover, how we characterize evidence, or what we conclude. Primary sources and study quality come first. Seller-provided descriptions are not treated as independent evidence.
OpenTides may earn commissions from clearly identified commercial links. We disclose that relationship near the relevant recommendation and link—not only in a footer or separate policy. We do not use hidden cookie-setting, misleading coupon language, or undisclosed endorsements.
OpenTides provides education, not diagnosis or individualized medical advice. We do not publish dosing, reconstitution, injection, cycling, stacking, titration, administration, or personal procurement instructions for unapproved or research-use-only products.
Material corrections should state what changed, why, and when. Regulatory status, prices, promotions, trial records, and safety communications are time-sensitive and should be re-verified before relying on them.
Authors and reviewers should disclose financial, professional, and personal conflicts relevant to a page. Substantive medical content requires qualified human editorial review before full public launch; high-risk commercial pages require U.S. healthcare regulatory counsel.
This first release does not use OpenTides analytics, email capture, accounts, payments, or advertising trackers. External destinations may apply their own privacy and cookie practices.
